kabutan

SymBio Pharma, The Current Fiscal Year's Net Income to Narrow

Thu Feb 5, 2026 3:30 pm JST Earnings

4582 SymBio Pharmaceuticals Limited 【J-GAAP】

Earnings Report

SymBio Pharmaceuticals Limited <4582> [TSE Growth] announced its financial results after the market closed on February 5th (15:30). The consolidated net loss for the fiscal year ended December 2025 expanded to a loss of 4.77 billion yen (compared to a loss of 3.83 billion yen in the previous period), but it is expected to shrink to loss of 4.33 billion yen for the fiscal year ending December 2026. This will mark the fourth consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 1.21 billion yen (compared to a loss of 0.98 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -195.8% in the same period last year to -326.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 5,589 -811 -736 -1,962 -49.2 0 Feb 8, 2024 J-GAAP
Dec, 2024 2,452 -3,876 -3,689 -3,833 -85.0 0 Feb 6, 2025 J-GAAP
Dec, 2025 1,307 -4,440 -4,647 -4,776 -95.1 0 Feb 5, 2026 J-GAAP
YoY -46.7% -14.6% -26.0% -24.6% -11.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2025 Guidance 1,400 -4,262 -4,467 -4,592 -82.3 0 Jun 10, 2025 J-GAAP
Dec, 2025 Results 1,307 -4,440 -4,647 -4,776 -95.1 0 Feb 5, 2026 J-GAAP
Revision Rate -6.6% -4.2% -4.0% -4.0% -15.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 646 -2,154 -2,340 -2,369 -49.4 0 Jul 31, 2025 J-GAAP
Jan - Jun, 2026 Guidance ー ー ー ー － 0 Feb 5, 2026 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 2,452 -3,876 -3,689 -3,833 -85.0 0 Feb 6, 2025 J-GAAP
Dec, 2025 1,307 -4,440 -4,647 -4,776 -95.1 0 Feb 5, 2026 J-GAAP
Dec, 2026 Guidance 3,891 -4,231 -4,291 -4,331 -72.8 0 Feb 5, 2026 J-GAAP
YoY +197.7% +4.7% +7.7% +9.3% +23.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 554 -1,085 -930 -988 -21.9 -195.8 Feb 6, 2025 J-GAAP
Jan - Mar, 2025 264 -1,169 -1,288 -1,321 -28.0 -442.8 May 8, 2025 J-GAAP
Apr - Jun, 2025 382 -985 -1,052 -1,048 -21.8 -257.9 Jul 31, 2025 J-GAAP
Jul - Sep, 2025 324 -1,185 -1,198 -1,196 -24.6 -365.7 Oct 30, 2025 J-GAAP
Oct - Dec, 2025 337 -1,101 -1,109 -1,211 -24.1 -326.7 Feb 5, 2026 J-GAAP
YoY -39.2% -1.5% -19.2% -22.6% -10.1%

Related Articles